baber/WOPTO huggingface dataset:
Patent NZ-205534-A (NZ)
Title: N-nitrosourea compounds and pharmaceutical compositions
Inventor: CARLSSON J-I L
IPC: A61K31/445
Filed: 1983-09-09
Abstract: The invention concerns N-nitroso compounds having the general formula:   <IMAGE> (I)  wherein A is lower alkyl or halolower alkyl; B is hydrogen; lower alkenyl; lower alkynyl; 3-6 C cycloalkyl; -RSO2NR3R4, or lower alkyl optionally monosubstituted with lower alkoxy, or 3-6 C cycloalkyl; R is straight or branched 2-5 C alkylene, optionally monosubstituted with SO2NR3R4 or CONR3R4, said alkylene always containing at least two carbon atoms separating the nitrogen atom of the urea from any SO2NR1R2 or SO2NR3R4; R1 and R2 are the same or different and selected from hydrogen, 5-6 C cycloalkyl, lower alkoxy, phenyl, benzyl, and straight or branched 1-6 C alkyl, optionally monosubstituted with hydroxy, lower alkoxy, SO2NR3R4, or CONR3R4; R1 and R2 may also together form a 4-5 C alkylene; and R3 and R4 are the same or different and selected from hydrogen or lower alkyl, or R3 and R4 together are a 4-5 C alkylene, together with pharmaceutical compositions thereof; processes for their manufacture, and methods of treatment. The compounds of formula (I) have antitumor activity.
Patent NZ-219222-A (NZ)
Title: A composition for priming hard tissue
Inventor: AASEN S M
IPC: A61K6/884
Filed: 1987-02-10
Abstract: An acid and a water-soluble film former are used as a primer for hard tissue (e.g., dentin). The acid has a pK<sub>a</sub> less than or equal to that of phenol and the acid and its calcium salt(s) are soluble in the film former. The primer is free of adhesively detrimental quantities of calcium salts that are not soluble in the film former.
Patent NZ-220615-A (NZ)
Title: Rotary element for spraying head of liquid distributor
Inventor: GILL D C
IPC: B05B3/10
Filed: 1987-06-09
Abstract: A rotary element (8), for distributing liquids such as herbicide, comprises a concave liquid receiving surface (22) including a conical outer portion (26). Teeth (28) project from the outer portion (26). Each tooth has an upper surface (30) which is inclined to the rotary axis of the element by a greater angle than is the outer portion (26). Each tooth has side surfaces (32) which extend parallel to the rotary axis and have a maximum axial dimension (t) which is greater than 0.01, and preferably 0.05, times the overall diameter of the element.
Patent NZ-222494-A (NZ)
Title: Separation of comminuted slaughterhouse waste into bone and meat protein phases using hydrocyclone
Inventor: HANSEN P-I
IPC: C09H1/02
Filed: 1987-11-09
Abstract: Bone-containing animal material, such as slaughterhouse waste which has been scoured and dewatered by pressing, is separated into a bone-containing phase and a meat protein-containing phase by stirring the material with water after comminution to form a suspension (2) which is subjected to a separation in a hydrocyclone (8). The suspension is hereby separated into a bone-containing phase leaving the cyclone through its bottom nozzle, and into a meat protein-containing phase leaving the cyclone through its vortex detector and being processsed into a protein product in a manner known per se. In the phase rich in meat protein at least about 70 weight-% of the dry matter is protein, whereas the bone-containing phase has a protein-content in the dry matter of less than 40 weight-%, including the ossein contained in the bones.
Patent NZ-227421-A (NZ)
Title: 1,4,7,10-tetraazacyclododecane derivatives and diagnosis using nmr
Inventor: FELDER ERNST
IPC: A61K51/00
Filed: 1988-12-20
Abstract: Macrocyclic derivatives of 1,4,7,10-tetraazacyclododecane of general formula I <CHEM>  wherein  A is a group of formula <CHEM>  in which R      is H or alkyl or optionally substituted benzyl or a H(OCH2CH2)1-4-, Me(OCH2CH2)1-4-, or Et(OCH2CH2)1-4- group, X      is O-R1, in which R1 is H or alkyl, hydroxyalkyl, alkoxyalkyl, alkoxyhydroxyalkyl or a polyoxaalkyl group or X is -NR2R3, in which R2 and R3 are H or alkyl, hydroxyalkyl, alkoxyalkyl or alkoxyhydroxyalkyl,  and B1, B2 and B3      have the same meanings as A or are H or a group of formula <CHEM>  in which R4      is H or alkyl, Y is a O-R5 group, wherein R5 is H or alkyl, hydroxyalkyl, alkoxyalkyl, alkoxyhydroxyalkyl or a polyoxaalkyl group, or Y is a -NR6R7 group, wherein R6 and R7 are H or alkyl, hydroxyalkyl, alkoxyalkyl or alkoxyhydroxyalkyl, said derivatives optionally being salified, and the complex salts thereof, are used as pharmaceuticals and/or diagnostic agents.
Patent NZ-227913-A (NZ)
Title: Penetrating coating compositions containing acrylates and antioxidative compounds
Inventor: LARSON DONALD BRUCE
IPC: D21H17/19
Filed: 1989-02-09
Abstract: Improved durability and water repellency are provided to porous substrates by the use of a novel penetrating treatment composition comprising (A) C10 to C22 alkyl acrylate(s) or methacrylate(s) which are non-oxidizing and polymerizable to form homopolymers having a glass transition temperature of about 0 DEG C or less and (B) autoxidative compound(s) which function as polymerization initiator-oxygen scavenger, wherein the weight ratio of (A) to (B) is about 50 to 95 to about 50 to 5.
Patent NZ-234735-A (NZ)
Title: Sputum collection system; wedged cap removable from sheild through side opening in shield wall
Inventor: BURNS JAMES A
IPC: A61B10/00
Filed: 1990-08-01
Abstract: A system is provided for easing the placement of the final screw cap (5) onto a sputum collection container (1) so as to avoid dropping the cap (5) or spilling the specimen in the container (1) onto the hands of the user. An opening (35) is provided in the side wall of the outer protective body (4) of the system so as to gain access to the cap (5) held wedged therein. The wedging action holds the screw cap (5) in place while the user rotates the specimen container (1) to cause cooperation between the screw threads of the screw cap (5) and the associated sputum collection container (1).
Patent NZ-235411-A (NZ)
Title: Antibodies produced to highly conserved amino acid sequences of insulin
Inventor: MULLNER STEFAN
IPC: A61K39/395
Filed: 1990-09-21
Abstract: The invention relates to antibodies which are obtained by immunisation with a peptide fragment which represents a highly conserved amino-acid sequence of a natural protein. The antibodies according to the invention can be used to produce immunoassays, in particular to produce assays for the determination of genetically engineered products such as insulin, which are produced as sparingly soluble inclusion bodies in microorganisms. The invention particularly relates to a multispecies insulin assay in the form of an RIA.
Patent NZ-237069-A (NZ)
Title: Detoxifying a toxic antigen from a selected pathogen for use as a human vaccinal agent
Inventor: CAPIAU CARINE
IPC: C12N1/00
Filed: 1991-02-11
Abstract: A detoxified B. pertussis toxin or antigenic preparation is described, which is characterized by stability to reversion to toxicity upon storage at 4-8  DEG C and at temperatures above 23  DEG C. Also provided are methods for producing detoxified pertussis toxin and vaccines containing same.
Patent NZ-238528-A (NZ)
Title: 3-aryl-2-hydroxypropionic acid derivatives, analogs, preparation and pharmaceutical compositions thereof
Inventor: HULIN BERNARD
IPC: A61K31/41
Filed: 1991-06-13
Abstract: Certain 3-(phenyl, chroman-2-yl, benzofuran-5-yl or benzoxazol-5-yl)-2-(hydroxy or mercapto)propionic acid derivatives and analogs are useful as hypoglycemic and hypocholesterolemic agents.
Patent NZ-250029-A (NZ)
Title: Combination vaccine with diphtheria, tetanus and pertussis antigens and a conjugate from fragments of haemophilus influenza capsular antigen and crm197
Inventor: PARADISO PETER R
IPC: A61P31/04
Filed: 1993-10-22
Abstract: A combined pediatric vaccine composition featuring, in a single immunizing dose, a mixture of diphtheria, tetanus and pertussis antigens and a conjugate of fragments of the capsular polysaccharide antigen of Haemophilus influenzae type b and CRM197 protein in a pharmaceutically acceptable aqueous vehicle is provided. The combined vaccine composition exhibits an enhanced antibody response by infants to each of the four vaccine components.
Patent NZ-263793-A (NZ)
Title: Compounds suitable for forming tc and re chelates, radiopharmaceutical compositions thereof
Inventor: HILGER CHRISTOPH-STEPHAN
IPC: C07K14/47
Filed: 1994-03-29
Abstract: PCT No. PCT/DE94/00370 Sec. 371 Date Mar. 8, 1996 Sec. 102(e) Date Mar. 8, 1996 PCT Filed Mar. 29, 1994 PCT Pub. No. WO94/22492 PCT Pub. Date Oct. 13, 1994This invention relates to new bifunctional chelating agents with intermittent chalcogen atoms, pharmaceuticals containing these compounds, their use in radiodiagnostics and radiotherapy, and methods for the production of these compounds. The compound according to the invention has the general formula (I) M-L wherein M represents a radionuclide of Tc or Re and L a ligand of the general formula (II) B-CO-CR1R2-A-CR3R4-CO-D(II) These new, bifunctional chelating agents with intermittent chalcogen atoms and their coupling products with compounds that accumulate specifically are suited for producing radiopharmaceuticals for diagnostic and therapeutic purposes.
Patent NZ-271822-A (NZ)
Title: Ring stabilized rapamycin derivatives and pharmaceutical use
Inventor: NELSON FRANCES CHRISTY
IPC: C07F7/18
Filed: 1994-08-10
Abstract: This invention provides C-22 substituted rapamycin derivatives of the following formulas:   <IMAGE>   or   <IMAGE>   and pharmaceutically acceptable salts thereof which are useful for inducing immunosuppression and treating transplantation rejection, host vs. graft disease, autoimmune diseases, diseases of inflammation, solid tumors, fungal infections, adult T-cell leukemia/lymphomas and hyperproliferative vascular disorders.
Patent NZ-282932-A (NZ)
Title: Biological water purification microbial film carrier element of predetermined dimensions and relative surface and opening areas
Inventor: GUNNARSSON LARS AKE HANS
IPC: B01J19/30
Filed: 1995-03-15
Abstract: PCT No. PCT/SE95/00260 Sec. 371 Date Feb. 25, 1997 Sec. 102(e) Date Feb. 25, 1997 PCT Filed Mar. 15, 1995 PCT Pub. No. WO95/25072 PCT Pub. Date Sep. 21, 1995The invention refers to a carrier element to be used as a carrier for a microbial film in a biological water or waste water purification process in which the carrier elements are kept moving in the water. The surface of the carrier element is partly protected against collision with the surfaces of the other carrier elements. The carrier element has flow passages therethrough and is moreover designed to allow good flow of water therethrough also after a microbial film having been established on the surfaces. The carrier element has a length, width and/or height which exceeds 1.5 cm, and the protected area is larger than 100 m2/m3 of the volume of the carrier element. The cross-sectional area of the passage opening in the boundary surface towards the surroundings of the element comprises at least 35% of the boundary surface towards the surroundings of a homogenous body having the same dimensions. The invention also relates to the use of such carrier elements for the treatment of waste water from the wood-processing industry, the waste water containing at least 100 mg/l suspended matter as measured on a GF/A-filter, as well as a reactor for biological water or waste water purification, comprising a reactor tank (20) which contains carrier elements (25) according to the invention and wherein a grid (26) covering the bottom of the tank is provided over aerators (21) at said bottom.
Patent NZ-313633-A (NZ)
Title: Pharmaceutical composition containing rapamycin in a solid dispersion with a carrier medium
Inventor: GUITARD PATRICE
IPC: A61K31/435
Filed: 1996-07-12
Abstract: A pharmaceutical composition for oral administration in the form of a solid dispersion comprising an ascomycin or a derivative thereof and a carrier medium.
Patent NZ-332777-A (NZ)
Title: 3,6-bi-phenyl substituted spiro-piperidine derivatives
Inventor: BAKER RAYMOND
IPC: A61P1/08
Filed: 1997-06-17
Abstract: The compounds have the formula I wherein: R1 is H, OH, alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, alkoxy, fluoroalkoxy, alkoxyalkyl, alkoxyalkoxy, fluoroalkoxyalkyl, alkenyloxy, cycloalkoxy, cycloalkylalkoxy, phenoxy, benzyloxy, cyano, halo, NRaRb, S(O)nRa, OS(O)nRa, NRaCOR14, CORa, CO2Ra or CONRaRb with Ra and Rb being independently H, alkyl or fluoroalkyl; R2 is H, halo, alkyl or alkoxy or when R2 is adjacent to R1, they together form a 5 or 6 membered optionally saturated optionally substituted ring containing one or two atoms selected from N, O or S; R3 is H, halo, optionally substituted alkyl, fluoroalkyl, cycloalkyl, cycloalkylalkyl, alkoxy, fluoroalkoxy, cyano, NRaRb, S(O)nRa, NRaCOR14, CORa, CO2Ra or CONRaRb; R4 is H, halo, optionally substituted alkyl, alkoxy, CF3, OCF3, NO2, CN, S(O)nRa, CONRaRb, CO2Ra, alkenyl or alkynyl; R5 is H, halo, alkyl, CF3 or alkoxyalkoxy; R6 is H, CORa, CO2Ra, COCONRaRb, COCO2Ra, optionally substituted alkyl, -CH2CºCCH2NR7R8; R9 and R10 are independently H, halo, alkyl, CH2ORe, oxo, CO2Ra or CONRaRb and R7 and R8 are as defined in the specification  or a pharmaceutically acceptable salt thereof. A pharmaceutical composition thereof is useful for treating or preventing pain, inflammation, migraines, emesis, depression and anxiety.
Patent NZ-335786-A (NZ)
Title: Amphiphilic graft polymers based on graft bases containing n-vinylcarboxylic acid units, process for their preparation and their use
Inventor: NEGELE ANTON
IPC: C09K23/22
Filed: 1997-11-28
Abstract: Disclosed are amphiphilic graft polymers in which the graft base is a polymer containing at least 5 wt % of units of formula (I) and optionally units of formula (II), R1, R2 being H or C1-C6 alkyl, wherein (a) styrene, C1-C2 alkylstyrene and/or vinyltoluene and optionally (b) other monoethylenically unsaturated monomers which can be copolymerized therewith are grafted onto the graft base in a weight ratio of between 1: 99 and 99: 1, and wherein the group (c) is optionally partially or completely cleaved off the graft polymers, forming amino groups. Also disclosed are processes for preparing and using the amphiphilic graft polymers as consolidating agents for paper, as fixing agents for disruptive water-soluble and water-insoluble agents in paper manufacture, as dispersants for inorganic and organic pigments, dyes, concrete and plant-protecting agents, as detergent additives, as coating material for fertilisers and plant-protecting agents, as floor-maintenance agents, as protective colloids for aqueous polymer dispersions, as thickeners for cosmetic formulations, as conditioners for skin-care agents and as a component of hair-cosmetic preparations and cosmetic preparations for oral hygiene.
Patent NZ-336403-A (NZ)
Title: Chip card stores applications for interaction with multiple service provider types
Inventor: ENGELHARDT HOLGER
IPC: G07B15/02
Filed: 1997-12-19
Abstract: A chip card for carrying out transactions in which value data representing units of monetary value or other, non-monetary entitlements, is transferred between the card holder and at least one transaction partner (service provider) or is presented to the service provider for verification of such entitlements includes a memory in which the data required for carrying out the transactions is stored. A facility for loading the card with one or more card applications (VAS applications), which in each case permit transactions to be carried out between the cardholder and one or more service providers, is provided on the card.  A transfer memory portion that is not proprietary to a service provider is provided for accommodating data which is interchanged or presented between different service providers in the performance of a transaction and which represents the monetary units or non-monetary entitlements.   The data is written into the transfer memory portion by a write command.
Patent NZ-503118-A (NZ)
Title: Synergistic antifungal compositions comprising imazalil and epoxiconazole
Inventor: BOSSELAERS JAN PIETER HENDRIK
IPC: A01N43/653
Filed: 1998-09-01
Abstract: Described are synergistic antifungal compositions which comprise imazalil (I), a salt, a stereoisomer or stereoisomeric mixture thereof, and epoxiconazole (II) a salt, a stereoisomer or stereoisomeric mixture thereof and a carrier. A product containing synergistically effective amounts of imazalil and epoxiconazole is also described as is the use of the composition for protecting plants or the loci thereof against fungi.
Patent NZ-503317-A (NZ)
Title: Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
Inventor: BEBBINGTON CHRIS
IPC: C12N1/21
Filed: 1998-09-23
Abstract: A retroviral vector useful as a gene delivery system is described.  The retroviral vector comprises a functional splice donor site and a functional splice acceptor site; where the splice donor site and the splice acceptor site flank a first nucleotide sequence of interest and the splice donor site is upstream of the splice acceptor site.  The retroviral vector is derived from a retroviral pro-vector where the retroviral pro-vector comprises the splice donor site downstream of the splice acceptor site.  Reverse transcription of the pro-vector to produce the retroviral vector orientates the splice donor site upstream of the splice acceptor site resulting in a functional splice site.
Patent NZ-504262-A (NZ)
Title: Method of manufacturing food products by injecting secondary component during extrusion
Inventor: HEYHOE THOMAS CARL
IPC: A23P1/12
Filed: 1998-10-01
Abstract: A method of manufacturing a food product wherein a cereal-based pre-mix including a first sensory component, which includes flavoring and/or coloring compounds, is fed into a hopper and fed from the hopper into an extruder, at a controlled rate. A liquid component including a second sensory component, which may also include flavoring and/or coloring compounds, is injected into the mix at a location intermediate the length of the extruder, the mix is then extruded to from the food product.
Patent NZ-505388-A (NZ)
Title: Polarization maintaining method in optical fibre
Inventor: PIANCIOLA AURELIO
IPC: G01M11/00
Filed: 1998-12-14
Abstract: A polarization-maintaining connector comprising a ferrule (2) inside which a polarization-maintaining fibre (F) is fixed, a lock ring (3) fitted over the ferrule (2), a first inner casing (4) in which the lock ring (3) is inserted, and an outer containing body (5) on which there is a key (51) which houses the inner casing (4).  The lock ring (3) has external circular symmetry and is free to rotate about its longitudinal axis inside the inner casing (4).
Patent NZ-506005-A (NZ)
Title: Recombinant proteins derived from hgf and msp
Inventor: MEDICO ENZO
IPC: C12N15/12
Filed: 1999-01-27
Abstract: Recombinant proteins derived from recombination of structural domains derived from the alpha subunits of HGF and/or MSP growth factors. The recombinant proteins have biological activity, and protect cells from death (apoptosis) induced by chemotherapeutic drugs. These molecules can be used to prevent or to treat the toxic side effects of chemotherapeutic agents used in cancer therapy.
Patent NZ-507275-A (NZ)
Title: Peptides compounds for delivering active agents across the blood-brain barrier
Inventor: LEONE-BAY ANDREA
IPC: A61K38/095
Filed: 2000-10-03
Abstract: A composition or salt thereof is described comprising: at least one active agent, and a compound, 8(N-2-Hydroxy-4-methoxybenzoyl) aminocaprylic acid (as shown). The biologically active agent could be interferon, interleukin-1, interleukin-II, insulin, heparin, calcitonin, oxytocin, vasopressin, vancomycin, desferrioxamine, parathyroid hormone, or any combination thereof.  This composition is to be passed across a mammalian blood/brain barrier.
Patent NZ-508401-A (NZ)
Title: Expandable preformed structures for deployment in interior body regions
Inventor: SCRIBNER ROBERT M
IPC: A61F2/958
Filed: 1999-06-01
Abstract: An expandable structure (56) made from an elastomer material is preformed to a desired geometry by exposure to heat, and pressure.  The structure (56) undergoes controlled expansion; further distention in cancellous bone, with controlled deformation, and without stress failure.
Patent NZ-511777-A (NZ)
Title: Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
Inventor: GIARDINA GIUSEPPE
IPC: C07D487/10
Filed: 1999-11-19
Abstract: A compound, its preparation process, a pharmaceutical composition and the use of this compound and composition in medicines is disclosed, wherein the compound is selected from the group consisting of: 1. 3-[1,4']Bipiperidinyl-1'-ylmethyl-2-phenyl-quinoline-4- carboxylic acid ((S)-1-cyclohexyl-ethyl)-amide 2. 3-{4-[2-(2-Hydroxy-ethoxy)-ethyl]-piperazin-1- ylmethyl}-2-phenyl-quinoline-4-carboxylic acid ((S)-1phenyl- propyl)-amide 3. 3-[4-(2-Hydroxy-ethyl)-piperazin-1-ylmethyl]-2-phenyl- quinoline-4-carboxylic acid ((S)-1-cyclohexyl-ethyl)-amide 4. 3-[4-(1-Methyl-piperidin-4-yl)-piperazin-1-ylmethyl]-2- phenyl-quinoline-4-carboxylic acid ((S)-1-phenyl-propyl)- amide 5. 3-[4-(1-Methyl-piperidin-4-yl)-piperazin-1-ylmethyl]-2- phenyl-quinoline-4-carboxylic acid ((S)-1-cyclohexyl-ethyl)- amide 6. 2-Phenyl-3-piperazin-1-ylmethyl-quinoline-4-carboxylic acid ((S)-1-cyclohexyl-ethyl)-amide 7. 3-[4-(2-Dimethylamino-ethanoyl)-piperazin-1-ylmethyl]- 2-phenyl-quinoline-4-carboxylic acid ((S)-1cyclohexyl- ethyl)-amide 8. 3-[4-(3-Diethylamino-propanoyl)-piperazin-1-ylmethyl]- 2-phenyl-quinoline-4-carboxylic acid ((S)-1-cyclohexyl- ethyl)-amide 9. 3-{4-[2-(4-Methyl-piperazin-1-yl)-ethanoyl]-piperazin- 1-ylmethyl}-2-phenyl-quinoline-4-carboxylic acid((S)-1- cyclohexyl-ethyl)-amide 10. ({4-[4-((S)-1-Cyclohexyl-ethylcarbamoyl)-2-phenyl- quinolin-3-ylmethyl]-piperazin-1-yl}-dimethylamino- methylene)-dimethyl-ammonium 11. 3-(4-Amino-piperidin-1-ylmethyl)-2-phenyl-quinoline-4- carboxylic acid ((S)-1-phenyl-propyl)-amide 12. 3-[4-(4-Methyl-piperidin-1-yl)-piperazin-1-ylmethyl]-2- phenyl-quinoline-4-carboxylic acid ((S)-1-phenyl-propyl)- amide 13. 3-[1,4']Bipiperidinyl-1'-ylmethyl-7-methoxy-2-phenyl- quinoline-4-carboxylic acid ((S)-1-phenyl-propyl)amide 14. 3-[4-(1-Methylimino-1-pyrrolidin-1-yl-methyl)- piperazin-1-ylmethyl]-2-phenyl-quinoline-4-carboxylic acid ((S)-1-cyclohexyl-ethyl)-amide 15. 3-[1,4']Bipiperidinyl-1'-ylmethyl-2-phenyl-quinoline-4- carboxylic acid ((S)-2-methyl-1-phenyl-propyl)amide 16. 3-[4-(3-Diethylamino-propanoyl)-piperazin-1-ylmethyl]- 2-phenyl-quinoline-4-carboxylic acid ((S)-2-methyl1-phenyl- propyl-amide 17. 3-[4-(2-Nitro-1-pyrrolidin-1-yl-vinyl)-piperazin-1- ylmethyl]-2-phenyl-quinoline-4-carboxylic acid ((S)- 1cyclohexyl-ethyl)-amide 18. 3-[1,4']Bipiperidinyl-1'-ylmethyl-7-hydroxy-2-phenyl- quinoline-4-carboxylic acid ((S)-1-phenyl-propyl)amide
Patent NZ-512108-A (NZ)
Title: Thiourea inhibitors of herpes viruses
Inventor: O'HARA BRYAN MARK
IPC: A61P31/22
Filed: 1999-12-06
Abstract: Compounds of formula (I), wherein: R1-R5   are   independently  H,  alkyl,  alkenyl,   alkynyl, perhaloalkyl,     cycloalkyl,    heterocycloalkyl,     aryl, heteroaryl,  halo, -CN, -NO2, -CO2R6, -COR6, -OR6,  -SR6,  - SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) or W-Y-(CH2)n- Z, R9-R12  are  independently  H,  alkyl,  perhaloalkyl,  halo, alkoxy,  or cyano, or R9 and R10 or R11 and R12 may together form aryl, G   is   optionally  substituted  aryl  or  fused   bicyclic heteroaryl, and X   is  a  bond,  -NH,  alkylene,  alkenylene,  alkyleneoxy, thioalkylene, alkyleneamino. The compounds are used in the manufacture of medicaments for inhibiting the replication of a herpes virus.
Patent NZ-513366-A (NZ)
Title: High solids clear coating composition
Inventor: UHLIANUK PETER WILLIAM
IPC: C08G18/38
Filed: 2000-03-16
Abstract: A method providing for a clear coating composition most suitable for use as a top clear coat in multi-layered OEM or refinish automotive coatings. The coating composition includes isocyanate and melamine components. The isocyanate component includes an aliphatic polyisocyanate. The composition may be formulated as a two-pack or one-pack coating composition, wherein the isocyanate functionalities are blocked with a blocker such as a mono-alcohol.